VerIQ is developing to a nationwide network of orthopaedic and MedTech clinical research sites, focusing initially on improved treatment for improved musculoskeletal health. This will strengthen the UK’s capability to deliver faster, higher-quality, and more cost-efficient clinical evidence and help get new products launched much sooner than is currently achieved.
The UK Government’s recently published Life Science Sector Plan highlighted the urgent need accelerate the delivery and reduce costs of conducting clinical studies in the UK. VerIQ has been designed to meet that need and will make a major difference to the ability of the UK to deliver world-leading clinical research for MedTech companies.
VerIQ Limited operates a coordinated, pre-qualified network of research-active hospitals and clinics supported by experienced investigators, research nurses, and academic partners. This “trial-ready” platform enables rapid study set-up, accelerated recruitment, and consistent, high-quality data delivery, addressing long-standing bottlenecks in MedTech evaluation. By utilising the world-leading academic and clinical resources in the UK, but in a package specifically designed for MedTech innovation, VerIQ aims to become a world leader in the rapid, efficient delivery of MedTech clinical research.
